BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19430501)

  • 21. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
    La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery.
    Dasta JF; Kane-Gill SL; Durtschi AJ; Pathak DS; Kellum JA
    Nephrol Dial Transplant; 2008 Jun; 23(6):1970-4. PubMed ID: 18178605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of mild acute kidney injury (AKI) on outcome after open repair of aortic aneurysms.
    Macedo E; Castro I; Yu L; Abdulkader RR; Vieira JM
    Ren Fail; 2008; 30(3):287-96. PubMed ID: 18350448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function after hematopoietic stem cell transplantation in children.
    Hazar V; Gungor O; Guven AG; Aydin F; Akbas H; Gungor F; Tezcan G; Akman S; Yesilipek A
    Pediatr Blood Cancer; 2009 Aug; 53(2):197-202. PubMed ID: 19353620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
    Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry.
    Crocchiolo R; Ciceri F; Fleischhauer K; Oneto R; Bruno B; Pollichieni S; Sacchi N; Sormani MP; Fanin R; Bandini G; Bonifazi F; Bosi A; Rambaldi A; Alessandrino PE; Falda M; Bacigalupo A
    Bone Marrow Transplant; 2009 Nov; 44(9):571-7. PubMed ID: 19363528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
    Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
    Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival in acute kidney injury after cardiac surgery.
    Thakar CV; Worley S; Arrigain S; Yared JP; Paganini EP
    Am J Kidney Dis; 2007 Nov; 50(5):703-11. PubMed ID: 17954283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT.
    Ando M; Mori J; Ohashi K; Akiyama H; Morito T; Tsuchiya K; Nitta K; Sakamaki H
    Bone Marrow Transplant; 2010 Sep; 45(9):1427-34. PubMed ID: 20062103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic kidney disease after nonmyeloablative stem cell transplantation in adults.
    Kersting S; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):403-8. PubMed ID: 18342782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and relationship with the quantity of transplanted cells.
    Tokgoz B; Kocyigit I; Polat G; Eser B; Unal A; Kaynar L; Sipahioglu MH; Oymak O; Utas C; Cetin M
    Ren Fail; 2010 Jun; 32(5):547-54. PubMed ID: 20486836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.
    Siegal D; Keller A; Xu W; Bhuta S; Kim DH; Kuruvilla J; Lipton JH; Messner H; Gupta V
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1369-79. PubMed ID: 17950923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial.
    Falda M; Busca A; Baldi I; Mordini N; Bruno B; Allione B; Rambaldi A; Morello E; Narni F; Santarone S; Locatelli F; Bacigalupo A;
    Am J Hematol; 2007 Oct; 82(10):863-6. PubMed ID: 17616972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RIFLE criteria for acute kidney injury in aortic arch surgery.
    Arnaoutakis GJ; Bihorac A; Martin TD; Hess PJ; Klodell CT; Ejaz AA; Garvan C; Tribble CG; Beaver TM
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1554-60; discussion 1560-1. PubMed ID: 18023682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.